By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Tokai Pharmaceuticals 

255 State Street

Boston  Massachusetts  02109  U.S.A.
Phone: 617-225-4305 Fax: n/a


SEARCH JOBS

Tokai Pharmaceuticals is focused on developing and delivering innovative therapies that provide hope and healing for patients living with cancer.

YEAR FOUNDED:

March 26, 2004

LEADERSHIP:

Founder: Joseph Yanchik, Seth Harrison

CEO: Jodie Morrison

CMO (Medical): Karen Ferrante

CFO: Lee Kalowski

JOBS:

Please click here for Tokai job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


PRODUCTS:

blank

FOLLOW TOKAI PHARMA:



Key Statistics


Email:
Ownership: Public

Web Site: Tokai Pharma
Employees:
Symbol: TKAI
 



Industry
Pharmaceutical






Company News
Struggling Tokai Pharma (TKAI) Nixes Enrollment in Mid-Stage Prostate Cancer Study 8/23/2016 6:25:56 AM
Tokai Pharma (TKAI) Axes 60% of Workforce After Phase III Prostate Cancer Trial Failure 7/29/2016 3:02:54 PM
Tokai Pharma (TKAI) to Terminate ARMOR3-SV Clinical Trial, Shares Tank 7/26/2016 5:55:16 AM
Tokai Pharmaceuticals (TKAI) To Participate In Upcoming Investor Conferences 6/2/2016 10:19:36 AM
Tokai Pharmaceuticals (TKAI) Announces Publication Of Three Abstracts On Galeterone At The 2016 ASCO Annual Meeting 5/19/2016 12:01:38 PM
Tokai Pharmaceuticals (TKAI) Reports First Quarter 2016 Financial Results 5/10/2016 12:28:05 PM
Tokai Pharmaceuticals (TKAI) To Present At The Bank of America (BAC) Merrill Lynch 2016 Health Care Conference 5/6/2016 9:25:26 AM
Tokai Pharmaceuticals (TKAI) To Present At The Bank of America (BAC) Merrill Lynch 2016 Health Care Conference 5/5/2016 11:02:03 AM
Tokai Pharmaceuticals (TKAI) Announces Oral Presentation On Galeterone At The 2016 American Urological Association Annual Meeting 4/26/2016 11:57:03 AM
Tokai Pharmaceuticals (TKAI) Announces Presentations On Galeterone At The AACR Annual Meeting 2016 4/13/2016 11:06:14 AM
12345678
//-->